Showing results (111-120 of 196) with videos related to
Sort By:
Pageof 20
Therapeutic Innovation & Regulatory Science|September 22, 2018
Adaptive Design: Results of 2012 Survey on Perception and UseCaroline Claire Morgan, Susan Huyck, Martin Jenkins, et al.Journal of the National Cancer Institute|November 1, 2007
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimensPeter F Thall, Christopher Logothetis, Lance C Pagliaro, et al.Cancer|September 5, 2002
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinomaDanai D Daliani, Christos N Papandreou, Peter F Thall, et al.Cancers|November 7, 2020
Adverse Event Burden Score-A Versatile Summary Measure for Cancer Clinical TrialsJennifer G Le-Rademacher, Shauna Hillman, Elizabeth Storrick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancerPaul Mathew, Peter F Thall, Donnah Jones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancerRandall Millikan, Peter F Thall, Sang-Joon Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostateChristos N Papandreou, Danai D Daliani, Peter F Thall, et al.The Oncologist|February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II studyLance C Pagliaro, Dallas L Williams, Danai Daliani, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2015
Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomasJingya Wang, Denái R Milton, Liru He, et al.Pageof 20